Cargando…

Trends in drug research III : proceedings of the 13th Noordwijkerhout-Caminero [sic] Symposium, the Netherlands, 6-11 May 2001 /

The tradition of setting new trends in medicinal chemistry continued at the 13th Symposium where topics included chemical and biological diversity, new paradigms in drug action, and new insights in receptor mechanisms. Other topics of great interest discussed, and included in these proceedings, are...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Noordwijkerhout-Camerino Symposium Noordwijkerhout, Netherlands
Otros Autores: Goot, H. van der
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Amsterdam ; New York : Elsevier, 2002.
Edición:1st ed.
Colección:Pharmacochemistry library ; v. 32.
Temas:
Acceso en línea:Texto completo
Texto completo
Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 SCIDIR_ocn162131241
003 OCoLC
005 20231117014856.0
006 m o d
007 cr cn|||||||||
008 070802s2002 ne a ob 101 0 eng d
040 |a OPELS  |b eng  |e pn  |c OPELS  |d OPELS  |d OCLCQ  |d N$T  |d YDXCP  |d MERUC  |d E7B  |d IDEBK  |d OCLCQ  |d OCLCF  |d OCLCO  |d NLGGC  |d OCLCQ  |d OCL  |d OCLCO  |d EBLCP  |d OCLCQ  |d UAB  |d PHUST  |d OCLCQ  |d CASUM  |d OCLCO  |d OCLCA  |d KIJ  |d STF  |d D6H  |d OCLCQ  |d OCLCO  |d OCLCA  |d LEAUB  |d OL$  |d OCLCQ  |d VLY  |d S2H  |d OCLCO  |d OCLCQ  |d OCLCO  |d COM  |d OCLCQ  |d OCLCO 
019 |a 182537129  |a 441810349  |a 647688766  |a 989422040  |a 1027505697  |a 1035702888  |a 1119449888  |a 1162263761  |a 1397426632 
020 |a 9780444507600 
020 |a 0444507604 
020 |a 9780080543239  |q (electronic bk.) 
020 |a 0080543235  |q (electronic bk.) 
020 |a 1281054976 
020 |a 9781281054975 
020 |a 9786611054977 
020 |a 6611054979 
035 |a (OCoLC)162131241  |z (OCoLC)182537129  |z (OCoLC)441810349  |z (OCoLC)647688766  |z (OCoLC)989422040  |z (OCoLC)1027505697  |z (OCoLC)1035702888  |z (OCoLC)1119449888  |z (OCoLC)1162263761  |z (OCoLC)1397426632 
050 4 |a RS420  |b .N665 2001eb 
060 4 |a W1  |b PH272L v.32 2002 
060 4 |a QV 744  |b N8175t 2002 
072 7 |a RS  |2 lcco 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
082 0 4 |a 615/.19  |2 22 
111 2 |a Noordwijkerhout-Camerino Symposium  |n (13th :  |d 2001 :  |c Noordwijkerhout, Netherlands) 
245 1 0 |a Trends in drug research III :  |b proceedings of the 13th Noordwijkerhout-Caminero [sic] Symposium, the Netherlands, 6-11 May 2001 /  |c edited by Henk van der Goot. 
246 3 |a Trends in drug research 3 
250 |a 1st ed. 
260 |a Amsterdam ;  |a New York :  |b Elsevier,  |c 2002. 
300 |a 1 online resource (ix, 262 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Pharmacochemistry library ;  |v v. 32 
520 |a The tradition of setting new trends in medicinal chemistry continued at the 13th Symposium where topics included chemical and biological diversity, new paradigms in drug action, and new insights in receptor mechanisms. Other topics of great interest discussed, and included in these proceedings, are the discoveries in green chemistry, the interface between organic synthesis and biosynthesis, the growing problem of resistant micro-organisms and the possibilities to identify new, and better, antibiotics. And finally, in recent developments, the discovery of small molecules with insulin sensitizing properties. 
504 |a Includes bibliographical references and indexes. 
505 0 |a Cover -- Contents -- Preface -- Chapter 1. Towards rational design of AMPA receptor ligands: an integrated medicinal, computational, biostructural and molecular pharmacological approach -- Chapter 2. From heparin to synthetic antithrombotics. The pentasaccharide story and follow-up -- Chapter 3. A new future for synthesis? -- Chapter 4. Directed evolution of enantioselective enzymes as catalysts in the production of chiral pharmaceuticals -- Chapter 5. At the interface of organic synthesis and biosynthesis -- Chapter 6. What can structure tell us about function in the estrogen receptors? -- Chapter 7. Molecular docking and dynamics simulations in the ligand binding domain of steroid hormone receptors -- Chapter 8. Peroxisome proliferator-activated receptors and reverse endocrinology -- Chapter 9. Biomolecular mass spectrometry related to drug research -- Chapter 10. Chemical and biological diversity in drug discovery -- Chapter 11. Muscarine acetylcholine receptor knockout mice: phenotypical analysis and clinical implications -- Chapter 12. Changes in expression of the orphan G-protein coupled receptor GPR7 in human painful peripheral neuropathies -- Chapter 13. Computational methods for the analysis of molecular diversity -- Chapter 14. Enhancing drug discovery by acquisition of chemical diversity -- Chapter 15. Chemical diversity as a driving force to design and put in practice synthetic strategies leading to combinatorial libraries for lead discovery and lead optimization -- Chapter 16. Beyond G proteins: the role of accessory proteins in G protein-coupled receptor signalling -- Chapter 17. Mechanisms of action of antipsychotic drugs: the role of inverse agonism at the D2 dopamine receptor -- Chapter 18. Agonist channeling of a2-adrenoceptor function -- Chapter 19. Antibacterials as wonder drugs and how their effectiveness is being compromised -- Chapter 20. Pseudomonas aeruginosa quorum sensing: a target for antipathogenic drug discovery -- Chapter 21. Discovery and development of new anti-bacterial drugs -- Chapter 22. Discovery of small molecule insulin mimetics as potential novel antidiabetic agents -- Chapter 23. Expression databases for pharmaceutical lead optimisation -- Chapter 24. New developments in the pharmacology of cannabinoids -- Author index -- Subject index -- Last Page. 
588 0 |a Print version record. 
546 |a English. 
650 0 |a Drugs  |x Design  |v Congresses. 
650 0 |a Pharmacology  |v Congresses. 
650 0 |a Pharmaceutical chemistry  |v Congresses. 
650 0 |a Drugs  |x Design. 
650 1 2 |a Drug Design  |0 (DNLM)D015195 
650 2 2 |a Chemistry, Pharmaceutical  |x trends  |0 (DNLM)D002626Q000639 
650 2 2 |a Pharmaceutical Preparations  |x chemistry  |0 (DNLM)D004364Q000737 
650 6 |a M�edicaments  |0 (CaQQLa)201-0203461  |x Conception  |0 (CaQQLa)201-0203461  |v Congr�es.  |0 (CaQQLa)201-0378219 
650 6 |a Pharmacologie  |0 (CaQQLa)201-0007219  |v Congr�es.  |0 (CaQQLa)201-0378219 
650 6 |a Chimie pharmaceutique  |0 (CaQQLa)201-0028674  |v Congr�es.  |0 (CaQQLa)201-0378219 
650 6 |a M�edicaments  |x Conception.  |0 (CaQQLa)201-0203461 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a Drugs  |x Design  |2 fast  |0 (OCoLC)fst00898790 
650 7 |a Pharmaceutical chemistry  |2 fast  |0 (OCoLC)fst01060115 
650 7 |a Pharmacology  |2 fast  |0 (OCoLC)fst01060259 
655 2 |a Congress  |0 (DNLM)D016423 
655 7 |a proceedings (reports)  |2 aat  |0 (CStmoGRI)aatgf300027316 
655 7 |a Conference papers and proceedings  |2 fast  |0 (OCoLC)fst01423772 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congr�es.  |2 rvmgf  |0 (CaQQLa)RVMGF-000001049 
700 1 |a Goot, H. van der. 
776 0 8 |i Print version:  |a Noordwijkerhout-Camerino Symposium (13th : 2001 : Noordwijkerhout, Netherlands).  |t Trends in drug research III.  |b 1st ed.  |d Amsterdam ; New York : Elsevier, 2002  |z 0444507604  |z 9780444507600  |w (DLC) 2002016031  |w (OCoLC)48783869 
830 0 |a Pharmacochemistry library ;  |v v. 32. 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780444507600  |z Texto completo 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/publication?issn=01657208&volume=32  |z Texto completo 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/bookseries/01657208/32  |z Texto completo